Viridian Therapeutics, Inc.
VRDN • NASDAQ • Stock Fundamentals
Viridian Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen F. Mahoney, with a market cap of $1.8B.
Market Cap$1.8B
Employees94.0
CEOStephen F. Mahoney
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Viridian Therapeutics, Inc. FAQ
Common questions about Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. (VRDN) has a market capitalization of $1.8B and trades on NASDAQ.
Viridian Therapeutics, Inc. has approximately 94 employees.